Inflammatory Breast Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer (IBC). Interventions: Drug: Ruxolitinib; Drug: Paclitaxel; Drug: Doxorubicin; Drug: Cyclophosphamide Sponsors: Dana-Farber Cancer Institute; Incyte Corporation Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2016 Category: Research Source Type: clinical trials
